Related Experiment Video
Updated: Jan 14, 2026

Exploring m6A and m5C Epitranscriptomes upon Viral Infection: an Example with HIV
Published on: March 5, 2022
Prevalence of N6-methyladenosine (m6A) in mycoplasma mRNA:Epitranscriptomic regulation in minimal genomes
Suzi Zhang1, Yuyu Zhang2, Yi Luo3
1State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, 730000, China; Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou, 730046, China; Key Laboratory of Veterinary Etiological Biology and Key Laboratory of Ruminant Disease Prevention and Control (West), Ministry of Agricultural and Rural Affairs, Lanzhou, 730046, China.
Abstract:
Messenger RNA N6 methyladenosine (m6A) modification has been considered as the main post-transcriptional modification of eukaryotic mRNA; however, its role in the regulation of prokaryotic mRNA transcription remains unclear. The N6 methyladenosine (m6A) modifications in prokaryotic mRNA has been found in Pseudomonas aeruginosa and Escherichia coli so far. In this study, ultra-high-pressure liquid chromatography coupled with triple quadrupole tandem mass spectroscopy (UHPLC-QQQ-MS/MS) was used to calculate the m6A/A ratio in multiple mRNA from a wide range of mycoplasma species, representing as a category of genomically minimal prokaryote. The results showed that mycoplasma mRNA has a higher m6A/A ratio than other prokaryotes and eukaryotes reported previously, varying in the range of 0.07-4.56 %. Furthermore, Nano UMI meRIP-seq analysis (a high-resolution long-read sequencing approach integrating unique molecular identifiers (UMIs) to map RNA methylation at the transcriptome level across eight different mycoplasma species. It showed that most m6A peaks are located in the protein coding region with unique "GGAGG" motif, which is different from those described in eukaryotes and other prokaryotes previously. Gene Ontology (GO) analysis showed that the genes regulated by this methylation modification system was involved in the ribosome, pyrimidine metabolism, purine metabolism, pyruvate metabolism and other metabolic pathways required for mycoplasma growth. To explore the potential functional impact of m6A methylation, we performed RNA pull-down assays and identified three virulent candidate m6A-binding proteins: Tuf (elongation factor Tu), prfA (peptide chain release factor A), and mgtA (magnesium transporter A). Microscale thermophoresis (MST) analysis also revealed that the three proteins exhibited significantly stronger binding affinities to m6A-modified RNA compared to their unmethylated counterparts, demonstrating their selective recognition of methylated transcripts. Further structural prediction using AlphaFold3 suggested specific amino acid residues mediating interactions with methylated adenines, offering mechanistic insights into m6A-protein interactions. Together, these findings firstly provided the landscape of m6A RNA methylation in mycoplasma and suggest that m6A may participate in post-transcriptional regulation by modulating RNA-protein interactions in mycoplasma genome, hinting that epitranscriptomic m6A regulation of mycoplasma mRNA may be associated with pathogenicity.
Insights
Messenger RNA N6 methyladenosine (m6A) modification is prevalent in mycoplasma, with higher ratios than previously reported. This study reveals m6A's role in regulating mycoplasma growth and potential pathogenicity through RNA-protein interactions.
Area of Science:
- Molecular Biology
- Genomics
- Epitranscriptomics
Background:
- Messenger RNA N6 methyladenosine (m6A) is a key eukaryotic post-transcriptional modification.
- Its role in prokaryotic mRNA transcription remains largely unexplored.
- Previous studies identified m6A in Pseudomonas aeruginosa and Escherichia coli.
Purpose of the Study:
- To investigate the prevalence and characteristics of m6A modification in mycoplasma mRNA.
- To identify m6A-binding proteins and understand their functional implications.
- To explore the potential role of m6A in mycoplasma pathogenicity.
Main Methods:
- Ultra-high-pressure liquid chromatography coupled with triple quadrupole tandem mass spectroscopy (UHPLC-QQQ-MS/MS) to quantify m6A/A ratio.
- Nano UMI meRIP-seq for transcriptome-wide m6A mapping.
- RNA pull-down assays and Microscale Thermophoresis (MST) for protein-RNA interactions.
- AlphaFold3 for structural prediction of protein-RNA interactions.
Main Results:
- Mycoplasma mRNA exhibits significantly higher m6A/A ratios (0.07-4.56%) compared to other prokaryotes and eukaryotes.
- m6A peaks are predominantly located in protein-coding regions, featuring a unique "GGAGG" motif.
- Genes regulated by m6A are involved in essential metabolic pathways and ribosome function.
- Three m6A-binding proteins (Tuf, PrfA, MgtA) were identified with high binding affinity to methylated RNA.
- Structural predictions revealed specific interactions between proteins and methylated adenines.
Conclusions:
- This study provides the first comprehensive landscape of m6A RNA methylation in mycoplasma.
- m6A modification in mycoplasma likely participates in post-transcriptional regulation via RNA-protein interactions.
- Epitranscriptomic regulation of mycoplasma mRNA by m6A may be linked to pathogenicity.
Related Concept Videos
RNA Stability
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
MicroRNAs
MicroRNAs
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

